AIP and pituitary tumor: Nevertheless, our identification of patients with AIP mutations will allow for cascade genetic screening of family members, the identification of additional mutation carriers, the clinical screening of these mutation carriers, and an earlier diagnosis, treatment and, possibly, better long-term outcome of any existing pituitary tumours [10].